Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Celine M VachonIsabel dos-Santos-Silva

Abstract

Mammographic density adjusted for age and body mass index (BMI) is a heritable marker of breast cancer susceptibility. Little is known about the biologic mechanisms underlying the association between mammographic density and breast cancer risk. We examined whether common low-penetrance breast cancer susceptibility variants contribute to interindividual differences in mammographic density measures. We established an international consortium (DENSNP) of 19 studies from 10 countries, comprising 16,895 Caucasian women, to conduct a pooled cross-sectional analysis of common breast cancer susceptibility variants in 14 independent loci and mammographic density measures. Dense and nondense areas, and percent density, were measured using interactive-thresholding techniques. Mixed linear models were used to assess the association between genetic variants and the square roots of mammographic density measures adjusted for study, age, case status, BMI, and menopausal status. Consistent with their breast cancer associations, the C-allele of rs3817198 in LSP1 was positively associated with both adjusted dense area (P = 0.00005) and adjusted percent density (P = 0.001), whereas the A-allele of rs10483813 in RAD51L1 was inversely associated wit...Continue Reading

References

Aug 1, 1995·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·H Lee-HanN F Boyd
May 1, 2001·Nature Medicine·K L NathansonK N Nathanson
Sep 20, 2002·The New England Journal of Medicine·Norman F BoydJohn L Hopper
Oct 1, 1994·Physics in Medicine and Biology·J W ByngM J Yaffe
Nov 15, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gerco HaarsPetra H M Peeters
Feb 3, 2006·Cancer Research·Gillian MitchellDouglas F Easton
Apr 15, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer StoneJohn L Hopper
Jun 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Valerie A McCormack, Isabel dos Santos Silva
Jan 19, 2007·The New England Journal of Medicine·Norman F BoydMartin J Yaffe
Feb 13, 2007·Nature Genetics·Angela CoxUNKNOWN Breast Cancer Association Consortium
May 29, 2007·Nature·Douglas F EastonBruce A J Ponder
Jun 6, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Valerie A McCormackIsabel dos Santos Silva
Oct 24, 2007·Cellular and Molecular Life Sciences : CMLS·F LaniganW M Gallagher
Nov 14, 2007·American Journal of Human Genetics·Antonis C AntoniouUNKNOWN Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Jan 18, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eunjung LeeGiske Ursin
Aug 7, 2008·Breast Cancer Research : BCR·Rulla M TamimiDavid J Hunter
Jan 7, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Giske UrsinThomas Mack
Feb 24, 2009·Breast Cancer Research : BCR·Christy G WoolcottLaurence N Kolonel
Mar 31, 2009·Nature Genetics·Shahana AhmedDouglas F Easton
Nov 20, 2009·International Journal of Cancer. Journal International Du Cancer·Valerie A McCormackIsabel Dos Santos Silva
Feb 10, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lisa J MartinNorman F Boyd
Feb 11, 2010·Cancer Research·Fabrice OdefreyUNKNOWN Australian Twins and Sisters Mammographic Density Study
Jun 23, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Snehal M Pinto PereiraIsabel dos-Santos-Silva

❮ Previous
Next ❯

Citations

Jun 28, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Barbara J FuhrmanGretchen L Gierach
Sep 13, 2013·Hereditary Cancer in Clinical Practice·Natalia BogdanovaThilo Dörk
May 15, 2013·Breast Cancer Research : BCR·Jennifer L CaswellElad Ziv
Sep 7, 2013·Breast Cancer Research : BCR·Hilda RazzaghiRobert C Millikan
Apr 15, 2014·BioMed Research International·Alexander HeinPeter A Fasching
Feb 27, 2014·Der Radiologe·R Schulz-WendtlandP A Fasching
Mar 13, 2014·Breast Cancer Research and Treatment·C W HuoE W Thompson
May 13, 2014·Journal of the National Cancer Institute·Andreas PetterssonRulla M Tamimi
Nov 8, 2014·Journal of the National Cancer Institute·Judith S BrandKamila Czene
Oct 15, 2013·American Journal of Epidemiology·Christy G WoolcottGertraud Maskarinec
Jun 16, 2015·American Journal of Human Genetics·Hatef DarabiGeorgia Chenevix-Trench
Jan 23, 2015·International Journal of Cancer. Journal International Du Cancer·Myrto BarrdahlDaniele Campa
Oct 30, 2014·International Journal of Cancer. Journal International Du Cancer·Pablo Fernandez-NavarroMarina Pollan
Apr 15, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Haiying DongJicheng Liu
Jul 15, 2015·Breast Cancer Research : BCR·Teresa Ramón Y CajalMarina Pollán
Jul 15, 2015·BMC Research Notes·Elizabeth J AtkinsonCeline M Vachon
Oct 2, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Pablo Fernandez-NavarroMarina Pollán
Mar 13, 2015·Cancer Causes & Control : CCC·Gertraud MaskarinecCeline M Vachon
May 1, 2016·Journal of the National Cancer Institute·Anne Marie McCarthyDespina Kontos
May 5, 2016·Breast Cancer Research : BCR·Michael J SherrattCharles H Streuli
Sep 25, 2015·PloS One·Charmaine Pei Ling LeeMikael Hartman
Feb 16, 2018·Climacteric : the Journal of the International Menopause Society·K E McLean, J Stone
Nov 5, 2014·Breast Cancer : Basic and Clinical Research·Phoebe S LeeStephen J Chanock
Mar 5, 2018·Breast Cancer Research and Treatment·Megan S RiceCeline M Vachon
Oct 7, 2017·Pathology Oncology Research : POR·Asuman ÖzgözMehmet Bacaksız
Jan 20, 2016·Oncotarget·Alastair J Ironside, J Louise Jones
Nov 30, 2019·Scientific Reports·Julie DutilAlvaro N Monteiro
Aug 11, 2018·Breast Cancer Research : BCR·Cecilia W HuoKara L Britt
Sep 13, 2012·Cancer Discovery·Yves A DeClerck
Oct 18, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jajini S VargheseDeborah J Thompson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.